Antithrombotic selection in patients undergoing transcatheter aortic valve replacement.Published in:American Journal of Health-System Pharmacy, 2021, v. 78, n. 1, p. 22, doi. 10.1093/ajhp/zxaa329By:Lai, Jennifer K;Willenborg, Katie L;Berei, Theodore;Rose, Anne EPublication type:Article
Pharmacist involvement in clinical assessment and laboratory testing for heparin-induced thrombocytopenia.Published in:Journal of Thrombosis & Thrombolysis, 2020, v. 50, n. 1, p. 195, doi. 10.1007/s11239-019-02011-8By:Condon, Amanda J.;Hood, Adam J.;Willenborg, Katie L.;Kumfer, Kraig;Rose, Anne E.Publication type:Article
Successful Use of Fondaparinux Early After Mechanical Aortic Valve Replacement in a Patient with a History of Heparin-Induced Thrombocytopenia.Published in:Pharmacotherapy, 2014, v. 34, n. 6, p. e55, doi. 10.1002/phar.1416By:Willenborg, Katie L.Publication type:Article